Circulating tumour necrosis factor α is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice

Parasite Immunology

Volumn 19, Issue 12, 1997, Pages 571-577

  Hermsen, C C ^a   Crommert, J V D ^a   Fredrix, H ^a   Sauerwein, R W ^a   Eling, W M C ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

anti TNF ; Cerebral malaria; P. berghei; TNF ; TNF R

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; RECEPTOR DENSITY;

ANIMALIA; PLASMODIUM BERGHEI; PROTOZOA;

EID: 0031467404     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1997.d01-175.x     Document Type: Article

References (23)

1. Aggarwal B.B. (1985) Human lymphotoxin. Methods Enzymology 116, 441-444
2. Bemelmans M.H., Abramowicz D. & Gouma D.J. et al. (1994) In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF and anti-IFN-gamma antibodies. Journal of Immunology 153, 499-506
3. Clark I.A., Ilschner S. & MacMicking J.D. et al. (1990) TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunology Letters 25, 195-198
4. Curfs J.H.A.J., Schalters T.P.M. & Hermsen C.C. et al. (1989) Immunological aspects of cerebral lesions in murine malaria. Clinical and Experimental Immunology 75, 136-140
5. Curfs J.H.A.J., Hermsen C.C. & Meuwissen J.H.E.Th. (1992) et al. Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology 105, 7-14
6. Deloron P., Lombard Roux P. & Ringwald P. et al. (1994) Plasma levels of TNF-α soluble receptors correlate with outcome in human falciparum malaria. European Cytokine Networke 5, 331-336
7. Echternacher B., Werner F. & Mannel D.N. et al. (1990) Requirement of endogenous tumour necrosis factor/cachectin for recovery from experimental peritonitis. Journal of Immunology 145, 3762-3766
8. Eling W.M.C. & Sauerwein R. (1995) Severe and cerebral malaria: common or distinct pathophysiology? Reviews in Medical Microbiology 6(1), 17-25
9. Fong Y., Tracey K.J. & Modawer L.L. et al. (1989) Antibody to cachectin/TNF reduce interleukin-1-beta and interleukin-6 appearance during lethal bacteremia. Journal of Experimental Medicine 170, 1627-1633
10. Garcia I., Miyazaki Y. & Araki K. et al. (1995) Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. European Journal of Immunology 25, 2401-2407
11. Grau G.E., Fajardo L.J. & Piquet P.F. et al. (1987) Tumour necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237, 1210-1212
12. Grau G.E., Taylor T.E. & Molyneux M.E. et al. (1989) Tumour necrosis factor and disease severity in children with falciparium malaria. New England Journal of Medicine 320, 1586-1591
13. Hensbroek van M.B., Palmer A. & Onyiorah E. et al. (1996) The effect of a monoclonal antibody to tumour necrosis factor on survival from childhood cerebral malaria. Journal of Infectious Diseases 174, 1091-1097
14. Kern P., Hemmer C.J. & Gallati H. et al. (1992) Soluble tumour necrosis factor receptors correlate with parasitemia and disease severity in human malaria. Journal of Infectious Diseases 166, 930-934
15. Kossodo de S., Houba V. & Grau G.E. (1995) Assaying tumour necrosis factor concentrations in human serum. A WHO international colaborative study. Journal of Immunological Methods 182, 107-114
16. Kremsner P.G., Winkler S. & Brandts C. et al. (1995) Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumour necrosis factor production. American Journal of Tropical Medicine and Hygiene 53, 532-538
17. Kwiatkowski D., Hill A.V.S. & Sambou I. et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201-1204
18. Kwiatkowski D., Molyneux M.E. & Stephens S. et al. (1993) Anti-TNF therapy inhibits fever in cerebral malaria. Quarterly Journal of Medicine 86, 91-98
19. McGuire W., Hill A. V. & Allsopp C.E. et al. (1994) Variation on the TNFα promotor region associated with susceptibility to cerebral malaria. Nature 371, 508-510
20. Molyneux M.E., Engelmann H. & Taylor T.E. et al. (1993) Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine 5, 604-609
21. Neill A.L. & Hunt N.H. (1995) Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology 111, 443-454
22. Shatter N., Grau G.E. & Hedberg K. et al. (1991) Tumour necrosis factor and severe malaria. Journal of Infection and Disease 163, 96
23. Yamada-Tanaka M.S., Fatima Ferreira-Cruz M. & das Gracas Alecrim M. et al. (1995) Tumour necrosis factor alpha. Interferon gamma and macrophage stimulating factor in relation to the severity of Plasmodium falciparum malaria in the Brazilian Amazone. Tropical and Geographical Medicine 6, 282-285